Intelligent Bio Solutions (INBS) Equity Ratio (2020 - 2024)
Intelligent Bio Solutions has reported Equity Ratio over the past 5 years, most recently at 0.65 for Q1 2024.
- Quarterly results put Equity Ratio at 0.65 for Q1 2024, up 16.18% from a year ago — trailing twelve months through Mar 2024 was 0.65 (up 16.18% YoY), and the annual figure for FY2023 was 0.36, down 32.81%.
- Equity Ratio for Q1 2024 was 0.65 at Intelligent Bio Solutions, up from 0.36 in the prior quarter.
- Over the last five years, Equity Ratio for INBS hit a ceiling of 0.94 in Q4 2020 and a floor of 2.11 in Q2 2020.
- Median Equity Ratio over the past 5 years was 0.57 (2022), compared with a mean of 0.4.
- Biggest five-year swings in Equity Ratio: soared 132.59% in 2021 and later plummeted 72.21% in 2023.
- Intelligent Bio Solutions' Equity Ratio stood at 0.94 in 2020, then decreased by 29.91% to 0.66 in 2021, then dropped by 13.75% to 0.57 in 2022, then plummeted by 37.16% to 0.36 in 2023, then soared by 80.63% to 0.65 in 2024.
- The last three reported values for Equity Ratio were 0.65 (Q1 2024), 0.36 (Q4 2023), and 0.14 (Q3 2023) per Business Quant data.